Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Gross Margin
Zylox-Tonbridge Medical Technology Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 3.6B HKD |
Gross Margin |
73%
|
Country | US |
Market Cap | 177.8B USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 142.6B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 129.9B USD |
Gross Margin |
64%
|
Country | US |
Market Cap | 111.1B USD |
Gross Margin |
69%
|
Country | IE |
Market Cap | 106.7B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 67.4B USD |
Gross Margin |
41%
|
Country | DE |
Market Cap | 59.7B EUR |
Gross Margin |
38%
|
Country | US |
Market Cap | 52.3B USD |
Gross Margin |
77%
|
Country | CN |
Market Cap | 350.9B CNY |
Gross Margin |
65%
|
Country | US |
Market Cap | 47B USD |
Gross Margin |
63%
|
Profitability Report
View the profitability report to see the full profitability analysis for Zylox-Tonbridge Medical Technology Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Zylox-Tonbridge Medical Technology Co Ltd's most recent financial statements, the company has Gross Margin of 73%.